Search

Your search keyword '"Scadding, Glenis K."' showing total 545 results
Start Over Author "Scadding, Glenis K."
545 results on '"Scadding, Glenis K."'

2. EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients

Author

Diamant, Zuzana, Jesenak, Milos, Hanania, Nicola A., Heaney, Liam G., Djukanovic, Ratko, Ryan, Dermot, Quirce, Santiago, Backer, Vibeke, Gaga, Mina, Pavord, Ian, Antolín-Amérigo, Darío, Assaf, Sara, Bakakos, Petros, Bobcakova, Anna, Busse, William, Kappen, Jasper, Loukides, Stelios, van Maaren, Maurits, Panzner, Petr, Pite, Helena, Spanevello, Antonio, Stenberg, Henning, Striz, Ilja, Thio, Boony, Vasakova, Martina Koziar, Conti, Diego, Fokkens, Wytske, Lau, Susanne, Scadding, Glenis K., Van Staeyen, Elizabeth, Hellings, Peter W., and Bjermer, Leif

Published
2023
Full Text
View/download PDF

5. What Is Nasal Hyperreactivity?

Author

Torun, Mümtaz Taner, Cingi, Cemal, Scadding, Glenis K., Cingi, Cemal, editor, Bayar Muluk, Nuray, editor, Scadding, Glenis K, editor, and Mladina, Ranko, editor

Published
2021
Full Text
View/download PDF

10. Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps.

Author

De Corso, Eugenio, Hellings, Peter W., Fokkens, Wytske J., Klimek, Ludger, Peters, Anju T., Scadding, Glenis K., Desrosiers, Martin, Lee, Stella E., and Mullol, Joaquim

Abstract

Purpose of the Review: Thymic stromal lymphopoietin (TSLP) is increasingly recognized for its pivotal role in the pathogenesis of various epithelial-driven chronic inflammatory diseases. This review navigates the existing evidence on TSLP, with a particular focus on asthma, before delving into the current understanding of its role in chronic rhinosinusitis with nasal polyps (CRSwNP). We explore the role of TSLP in the pathogenesis of asthma and CRSwNP, two conditions often interconnected and collectively referred to as"Global Airway Disease". Additionally, this review assesses the therapeutic potential of TSLP inhibition as a treatment option for both CRSwNP and asthma. A systematic literature search was conducted; selected publications were used to describe the biology of TSLP, including its expression and diverse effects on inflammation. Recent Findings: The role of TSLP in asthma is well established and supported by the efficacy of tezepelumab, the first anti-TSLP monoclonal antibody approved for both type 2 (T2)-high and T2-low severe asthma. TSLP may be a key contributor to CRSwNP pathogenesis as evidenced by genetic and mechanistic studies in which TSLP has been shown to regulate T2 inflammation and influence non-T2 responses. Preliminary data from the NAVIGATOR trial indicate that tezepelumab may reduce CRSwNP symptoms in patients with comorbid asthma. Summary: While further research is required to clarify the extent of TSLP contribution in CRSwNP, this review highlights the potential of anti-TSLP therapies as a novel approach for managing severe, uncontrolled CRSwNP. If these preliminary findings are confirmed, targeting TSLP could become a promising strategy to treat CRSwNP with or without comorbid asthma. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

11. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates inCOVID-19

Author

Rouadi, Philip W., Idriss, Samar A., Bousquet, Jean, Laidlaw, Tanya M., Azar, Cecilio R., Al-Ahmad, Mona S., Yañez, Anahi, Al-Nesf, Maryam Ali Y., Nsouli, Talal M., Bahna, Sami L., Abou-Jaoude, Eliane, Zaitoun, Fares H., Hadi, Usamah M., Hellings, Peter W., Scadding, Glenis K., Smith, Peter K., Morais-Almeida, Mario, Maximiliano Gómez, René, Gonzalez Diaz, Sandra N., Klimek, Ludger, Juvelekian, Georges S., Riachy, Moussa A., Canonica, Giorgio Walter, Peden, David, Wong, Gary W.K., Sublett, James, Bernstein, Jonathan A., Wang, Lianglu, Tanno, Luciana K., Chikhladze, Manana, Levin, Michael, Chang, Yoon-Seok, Martin, Bryan L., Caraballo, Luis, Custovic, Adnan, Ortego-Martell, Jose Antonio, Lesslar, Olivia J.Ly, Jensen-Jarolim, Erika, Ebisawa, Motohiro, Fiocchi, Alessandro, and Ansotegui, Ignacio J.

Published
2022
Full Text
View/download PDF

13. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates inCOVID-19

Author

Rouadi, Philip W., Idriss, Samar A., Bousquet, Jean, Laidlaw, Tanya M., Azar, Cecilio R., Al-Ahmad, Mona S., Yañez, Anahi, Al-Nesf, Maryam Ali Y., Nsouli, Talal M., Bahna, Sami L., Abou-Jaoude, Eliane, Zaitoun, Fares H., Hadi, Usamah M., Hellings, Peter W., Scadding, Glenis K., Smith, Peter K., Morais-Almeida, Mario, Gómez, René Maximiliano, Gonzalez Diaz, Sandra N., Klimek, Ludger, Juvelekian, Georges S., Riachy, Moussa A., Canonica, Giorgio Walter, Peden, David, Wong, Gary W.K., Sublett, James, Bernstein, Jonathan A., Wang, Lianglu, Tanno, Luciana K., Chikhladze, Manana, Levin, Michael, Chang, Yoon-Seok, Martin, Bryan L., Caraballo, Luis, Custovic, Adnan, Ortega-Martell, Jose Antonio, Jensen-Jarolim, Erika, Ebisawa, Motohiro, Fiocchi, Alessandro, and Ansotegui, Ignacio J.

Published
2021
Full Text
View/download PDF

14. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways

Author

Rouadi, Philip W., Idriss, Samar A., Bousquet, Jean, Laidlaw, Tanya M., Azar, Cecilio R., Sulaiman AL-Ahmad, Mona, Yáñez, Anahí, AL-Nesf, Maryam Ali Y., Nsouli, Talal M., Bahna, Sami L., Abou-Jaoude, Eliane, Zaitoun, Fares H., Hadi, Usamah M., Hellings, Peter W., Scadding, Glenis K., Smith, Peter K., Morais-Almeida, Mario, Gómez, R. Maximiliano, González Díaz, Sandra N., Klimek, Ludger, Juvelekian, Georges S., Riachy, Moussa A., Canonica, Giorgio Walter, Peden, David, Wong, Gary W.K., Sublett, James, Bernstein, Jonathan A., Wang, Lianglu, Tanno, Luciana Kase, Chikhladze, Manana, Levin, Michael, Chang, Yoon-Seok, Martin, Bryan L., Caraballo, Luis, Custovic, Adnan, Ortega-Martell, José Antonio, Jensen-Jarolim, Erika, Ebisawa, Motohiro, Fiocchi, Alessandro, and Ansotegui, Ignacio J.

Published
2021
Full Text
View/download PDF

17. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

Author

Bousquet, Jean, Schünemann, Holger J., Togias, Akdis, Bachert, Claus, Erhola, Martina, Hellings, Peter W., Klimek, Ludger, Pfaar, Oliver, Wallace, Dana, Ansotegui, Ignacio, Agache, Ioana, Bedbrook, Anna, Bergmann, Karl-Christian, Bewick, Mike, Bonniaud, Philippe, Bosnic-Anticevich, Sinthia, Bossé, Isabelle, Bouchard, Jacques, Boulet, Louis-Philippe, Brozek, Jan, Brusselle, Guy, Calderon, Moises A., Canonica, Walter G., Caraballo, Luis, Cardona, Vicky, Casale, Thomas, Cecchi, Lorenzo, Chu, Derek K., Costa, Elisio M., Cruz, Alvaro A., Czarlewski, Wienczyslawa, D'Amato, Gennaro, Devillier, Philippe, Dykewicz, Mark, Ebisawa, Motohiro, Fauquert, Jean-Louis, Fokkens, Wytske J., Fonseca, Joao A., Fontaine, Jean-François, Gemicioglu, Bilun, van Wijk, Roy Gerth, Haahtela, Tari, Halken, Susanne, Ierodiakonou, Despo, Iinuma, Tomohisa, Ivancevich, Juan-Carlos, Jutel, Marek, Kaidashev, Igor, Khaitov, Musa, Kalayci, Omer, Kleine Tebbe, Jorg, Kowalski, Marek L., Kuna, Piotr, Kvedariene, Violeta, La Grutta, Stefania, Larenas-Linnemann, Désirée, Lau, Susanne, Laune, Daniel, Le, Lan, Lieberman, Philipp, Lodrup Carlsen, Karin C., Lourenço, Olga, Marien, Gert, Carreiro-Martins, Pedro, Melén, Erik, Menditto, Enrica, Neffen, Hugo, Mercier, Gregoire, Mosgues, Ralph, Mullol, Joaquim, Muraro, Antonella, Namazova, Leyla, Novellino, Ettore, O'Hehir, Robyn, Okamoto, Yoshitaka, Ohta, Ken, Park, Hae Sim, Panzner, Petr, Passalacqua, Giovanni, Pham-Thi, Nhan, Price, David, Roberts, Graham, Roche, Nicolas, Rolland, Christine, Rosario, Nelson, Ryan, Dermot, Samolinski, Boleslaw, Sanchez-Borges, Mario, Scadding, Glenis K., Shamji, Mohamed H., Sheikh, Aziz, Bom, Ana-Maria Todo, Toppila-Salmi, Sanna, Tsiligianni, Ioana, Valentin-Rostan, Marylin, Valiulis, Arunas, Valovirta, Erkka, Ventura, Maria-Teresa, Walker, Samantha, Waserman, Susan, Yorgancioglu, Arzu, and Zuberbier, Torsten

Published
2020
Full Text
View/download PDF

20. Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.

Author

Ansotegui, Ignacio J., Bousquet, Jean, Canonica, Giorgio Walter, Demoly, Pascal, Gómez, Rene Maximiliano, Meltzer, Eli O., Murrieta-Aguttes, Margarita, Naclerio, Robert M., Rosario Filho, Nelson, and Scadding, Glenis K.

Subjects
POSITRON emission tomography, PSYCHOLOGY of movement, RANDOMIZED controlled trials, CENTRAL nervous system, ALLERGIES
Abstract

Fexofenadine is a second-generation inverse agonist of H1-receptor of histamine which is highly selective with proven efficacy in relieving symptoms associated with allergic conditions. It has an additional benefit of not penetrating the blood–brain barrier and therefore do not induce sedation and not impair the cognitive function/psychomotor performance. This review aimed at providing evidence based on available controlled studies to reinforce the non-sedative property of fexofenadine for treating patients with allergic rhinitis and urticaria. We performed an electronic literature search using keywords such as fexofenadine, drowsiness, somnolence, sedation, fatigue, cognitive, impairment, psychomotor, driving performances, sleep, rapid eye movement, alertness, clinical study, in vitro study, in vivo study, and pharmacodynamics in the Embase search engine. The review included randomized controlled trials, review articles, systematic reviews, and meta-analyses, together with post-marketing analysis conducted in healthy subjects and patients with allergy and were focused on comparing the antihistaminic potential or safety of fexofenadine with other antihistamines or placebo. Positron emission tomography (PET) and proportional impairment ratio (PIR) data along with other objective tests from various studies confirmed the non-sedative property of fexofenadine. Results of brain H1-receptor occupancy (H1RO) obtained from PET showed no H1RO by fexofenadine, the receptor which is known to cause sedation of H1 antihistamines. Most studies calculating PIR value as 0 showed fexofenadine to be a non-impairing oral antihistamine regardless of dose. Clinical trials in adults and children showed fexofenadine to be well tolerated without sedative effect or impairment of cognitive/psychomotor function even at higher than recommended doses. Published literature based on various parameters and clinical trials conducted for evaluating the effect of fexofenadine on sedation and central nervous system shows fexofenadine is both clinically effective and non-sedating. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus.

Author

Conti, Diego M., Vibeke, Backer, Kirsten, Beyer, Leif, Bjermer, Adam, Chaker, Stephanie, Dramburg, Mina, Gaga, Monika, Gappa, Philippe, Gevaert, Eckard, Hamelmann, Hellings, Peter W., Milos, Jesenak, Kopp, Matthias V., Marcus, Maurer, Marcia, Podesta, Dermot, Ryan, Scadding, Glenis K., Eike, Wüstenberg, Ulrich, Wahn, and Susanne, Lau

Subjects
PEDIATRIC clinics, SKIN diseases, RESPIRATORY diseases, PRIMARY health care, NONPROFIT organizations, PEDIATRIC dermatology, DISEASE remission, DERMATOLOGISTS
Abstract

The European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi‐annual forum EUFOREUM in Berlin in November 2023. The aim of EUFOREUM 2023 was to highlight pediatric action plans for prevention and optimizing care for type 2 inflammatory conditions starting in childhood, with a focus on early‐stage diagnosis, ensuring neither under‐ nor overdiagnosis, optimal care, and suggestions for improvement of care. EUFOREA is an international not‐for‐profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic respiratory diseases through the implementation of optimal patient care via educational, research, and advocacy activities. The inclusive and multidisciplinary approach of EUFOREA was reflected in the keynote lectures and faculty of the virtual EUFOREUM 2023 (www.euforea.eu/euforeum) coming from the pediatric, allergology, pulmonology, ENT, dermatology, primary health care fields and patients around the central theme of type 2 inflammation. As most type 2 inflammatory conditions may start in childhood or adolescence, and most children have type 2 inflammation when suffering from a respiratory or skin disease, the moment has come to raise the bar of ambitions of care, including prevention, remission and disease modification at an early stage. The current report provides a comprehensive overview of key statements by the faculty of the EUFOREUM 2023 and the ambitions of EUFOREA allowing all stakeholders in the respiratory field to be updated and ready to join forces in Europe and beyond. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. Allergic rhinitis

Author

Bousquet, Jean, Anto, Josep M., Bachert, Claus, Baiardini, Ilaria, Bosnic-Anticevich, Sinthia, Walter Canonica, G., Melén, Erik, Palomares, Oscar, Scadding, Glenis K., Togias, Alkis, and Toppila-Salmi, Sanna

Published
2020
Full Text
View/download PDF

33. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

Author

Aberer, Werner, Adachi, Mitsuru, Agache, Ioana, Akdis, Cezmi, Akdis, Mubeccel, Annesi-Maesano, Isabella, Ansotegui, Ignacio J., Anto, Josep M., Arshad, S. Hasan, Baiardini, Ilaria, Baigenzhin, Abay K., Barbara, Cristina, Bateman, Eric D., Beghé, Bianca, Bel, Elisabeth H., Ben Kheder, Ali, Bennoor, Kazi S., Benson, Michael, Bernstein, David, Michael, Bewick, Thomas, Bieber, Bindslev-Jensen, Carsten, Bjermer, Leif, Blain, Hubert, Boner, Attilio, Bonini, Matteo, Bonini, Sergio, Bosse, Isabelle, Bouchard, Jacques, Boulet, Louis-Philippe, Bourret, Rodolphe A., Bousquet, Philippe J., Braido, Fulvio, Briggs, Andrew H., Brightling, Christopher E., Buhl, Roland, Burney, Peter, Bush, Andrew, Caballero-Fonseca, Fernando, Caimmi, Davide P., Camargos, Paulo, Camuzat, Thierry, Carlsen, Kai-Hakon, Carr, Warner, Casale, Thomas B., Sarabia, Alfonso Cepeda, Chatzi, Leda, Chen, Yuzhi, Chiron, Raphaël, Chkhartishvili, Ekaterine, Chuchalin, Alexander, Ciprandi, Georgio, Cirule, Ieva, Correia de Sousa, Jaime, Costa, David, Crooks, George, Custovic, Adnan, Dahlen, Sven-Erik, Darsow, Ulf, De Blay, Frédéric, De Manuel Keenoy, Esteban, Dedeu, Tony, Deleanu, Diana, Denburg, Judah, Didier, Alain, Dinh-Xuan, Anh-Tuan, Dokic, Dejan, Douagui, Habib B., Dubakiene, Ruta, Durham, Stephen, Dykewicz, Mark, El-Gamal, Yehia, Emuzyte, Regina, Fink-Wagner, Antje, Fiocchi, Alessandro, Forastiere, Francesco, Gamkrelidze, Amiran, Gemicioğlu, Bilun, Gereda, Jose E., Gerth van Wijk, Roy, Gotua, Maia, Grisle, Ineta, Guzmán, M. Antonieta, Haahtela, Tari, Heinrich, Joachim, Hellquist-Dahl, Birthe, Horak, Friedrich, Howarth, Peter H., Humbert, Marc, Hyland, Michael, Ivancevich, Juan-Carlos, Jares, Edgardo J., Johnston, Sebastian L., Jonquet, Olivier, Joos, Guy, Jung, Ki-Suck, Just, Jocelyne, Jutel, Marek, Kaidashev, Igor P., Khaitov, Musa, Kalayci, Omer, Kalyoncu, Fuat, Keith, Paul, Khaltaev, Nikolai, Kleine-Tebbe, Jorg, Klimek, Ludger, N'Goran, Bernard Koffi, Kolek, Vitezlav, Koppelman, Gerard H., Kowalski, Marek, Kull, Inger, Kvedariene, Violeta, Lambrecht, Bart, Lau, Susanne, Laune, Daniel, Le Thi Tuyet, Lan, Li, Jing, Lieberman, Phillipe, Lipworth, Brian J., Renaud, Louis, Magard, Yves, Magnan, Antoine, Mahboub, Bassam, Majer, Ivan, Makela, Mika, Manning, Peter J., Masjedi, Mohamad R., Maurer, Marcus, Mavale-Manuel, Sandra, Melén, Erik, Melo-Gomes, Elisabete, Mercier, Jacques, Merk, Hans, Miculinic, Neven, Mihaltan, Florin, Milenkovic, Branislava, Mohammad, Yousser, Molimard, Mathieu, Momas, Isabelle, Montilla-Santana, Anna, Morais-Almeida, Mario, Mösges, Ralph, Nadif, Rachel, Namazova-Baranova, Leyla, Neffen, Hugo, Nekam, Kristof, Neou, Angelos, Niggemann, Bodo, Nyembue, Dieudonné, O'Hehir, Robyn, Ohta, Ken, Okamoto, Yoshitaka, Okubo, Kim, Ouedraogo, Solange, Paggiaro, Pier-Luigi, Pali-Schöll, Isabella, Palmer, Stephen, Panzner, Petr, Papi, Alberto, Park, Hae-Sim, Pavord, Ian, Pawankar, Ruby, Pfaar, Oliver, Picard, Robert, Pigearias, Bernard, Pin, Isabelle, Plavec, Davor, Pohl, Wolfgang, Popov, Todor, Postma, Dirkje S., Potter, Paul, Poulsen, Lars K., Rabe, Klaus F., Raciborski, Filip, Pontal, Françoise Radier, Reitamo, Sakari, Repka-Ramirez, Maria-Susana, Robalo-Cordeiro, Carlos, Roberts, Graham, Rodenas, Francisco, Rolland, Christine, Rodriguez, Miguel Roman, Romano, Antonino, Rosado-Pinto, José, Rosario, Nelson A., Rosenwasser, Larry, Rottem, Menachem, Sanchez-Borges, Mario, Sastre-Dominguez, Joaquim, Schmid-Grendelmeier, Peter, Serrano, Eli, Simons, F. Estelle R., Sisul, Juan-Carlos, Skrindo, Ingebjorg, Smit, Henriette A., Solé, Dirceu, Sooronbaev, Talant, Spranger, Otto, Stelmach, Rafael, Strandberg, Timo, Sunyer, Jordi, Thijs, Carel, Todo-Bom, Ana-Maria, Triggiani, Massimo, Valenta, Rudolf, Valero, Antonio L., van Hage, Marianne, Vandenplas, Olivier, Vezzani, Giorgio, Vichyanond, Pakit, Viegi, Giovanni, Wagenmann, Martin, Wahn, Ulrich, De Yun, Wang, Williams, Denis, Wright, John, Yawn, Barbara P., Yiallouros, Panayiotis, Yusuf, Osman M., Zar, Heather J., Zernotti, Mario, Zhang, Luo, Zhong, Nanshan, Zidarn, Mihaela, Bousquet, Jean, Schünemann, Holger J., Hellings, Peter W., Arnavielhe, Sylvie, Bachert, Claus, Bedbrook, Anna, Bergmann, Karl-Christian, Bosnic-Anticevich, Sinthia, Brozek, Jan, Calderon, Moises, Canonica, G. Walter, Chavannes, Niels H., Cox, Linda, Chrystyn, Henry, Cruz, Alvaro A., Dahl, Ronald, De Carlo, Giuseppe, Demoly, Pascal, Devillier, Phillipe, Dray, Gérard, Fletcher, Monica, Fokkens, Wytske J., Fonseca, Joao, Gonzalez-Diaz, Sandra N., Grouse, Lawrence, Keil, Thomas, Kuna, Piotr, Larenas-Linnemann, Désirée, Lodrup Carlsen, Karin C., Meltzer, Eli O., Mullol, Jaoquim, Muraro, Antonella, Naclerio, Robert N., Palkonen, Susanna, Papadopoulos, Nikolaos G., Passalacqua, Giovanni, Price, David, Ryan, Dermot, Samolinski, Boleslaw, Scadding, Glenis K., Sheikh, Aziz, Spertini, François, Valiulis, Arunas, Valovirta, Erkka, Walker, Samantha, Wickman, Magnus, Yorgancioglu, Arzu, and Zuberbier, Torsten

Published
2016
Full Text
View/download PDF

36. A EUFOREA comment on a lost comorbidity of asthma

Author

Conti, Diego M, Hellings, Peter W, Diamant, Zuzana, Bjermer, Leif, Jesenak, Milos, Backer, Vibeke, Fokkens, Wytske, Lau, Susanne, Van Staeyen, Elizabeth, and Scadding, Glenis K

Subjects
Chronic rhinosinusitis without nasal polyps, Allergic rhinitis, Asthma, Chronic rhinosinusitis with nasal polyps, Comorbidities
Abstract

"Epidemiology of comorbidities and their association with asthma control" (Tomisa, G., Horváth, A., Sánta, B. et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol 17, 95 (2021). https://doi.org/10.1186/s13223-021-00598-3 ) is an interesting paper reflecting data collection from more than 12,000 asthmatic patients in Hungary regarding their condition and associated comorbidities. We found it valuable that the paper provides an overview of asthma comorbidities not usually considered in similar reports. Nevertheless, we believe that chronic rhinosinusitis (CRS) with or without nasal polyps (CRSwNP or CRSsNP) should have been listed due to its high incidence and prevalence, its association with asthma which is also endorsed in both GINA and EPOS, as well as in several peer-reviewed scientific papers, and to reflect the role of this comorbidity in poor control and a most severe presentation of asthma for the patient. Consequently, several targeted therapies (especially monoclonal antibodies) used for several years in severe forms of asthma are now indicated also for the effective treatment of nasal polyps. ispartof: ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY vol:19 issue:1 ispartof: location:England status: published

Published
2023

38. EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]

Author

Scadding,Glenis K, Smith,Peter K, Hellings,Peter W, Scadding,Glenis K, Smith,Peter K, and Hellings,Peter W

Abstract

Glenis K Scadding,1,* Peter K Smith,2,* Peter W Hellings3,4,* 1Department of Allergy & Rhinology, Royal National ENT Hospital; Division of Immunity and Infection, University College, London, UK; 2Griffith University, School of Medicine, Southport, Queensland, 4215, Australia; 3Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals, Leuven, Belgium; 4Upper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium*These authors contributed equally to this workCorrespondence: Glenis K Scadding, Royal National ENT Hospital, 6 Huntley Street, London, W1E 6DG, UK, Tel +442087236045, Email g.scadding@ucl.ac.uk

Published
2023

39. EUFOREA pocket guide on the diagnosis and management of asthma:An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients

Author

Diamant, Zuzana, Jesenak, Milos, Hanania, Nicola A., Heaney, Liam G., Djukanovic, Ratko, Ryan, Dermot, Quirce, Santiago, Backer, Vibeke, Gaga, Mina, Pavord, Ian, Antolín-Amérigo, Darío, Assaf, Sara, Bakakos, Petros, Bobcakova, Anna, Busse, William, Kappen, Jasper, Loukides, Stelios, van Maaren, Maurits, Panzner, Petr, Pite, Helena, Spanevello, Antonio, Stenberg, Henning, Striz, Ilja, Thio, Boony, Vasakova, Martina Koziar, Conti, Diego, Fokkens, Wytske, Lau, Susanne, Scadding, Glenis K., Van Staeyen, Elizabeth, Hellings, Peter W., Bjermer, Leif, Diamant, Zuzana, Jesenak, Milos, Hanania, Nicola A., Heaney, Liam G., Djukanovic, Ratko, Ryan, Dermot, Quirce, Santiago, Backer, Vibeke, Gaga, Mina, Pavord, Ian, Antolín-Amérigo, Darío, Assaf, Sara, Bakakos, Petros, Bobcakova, Anna, Busse, William, Kappen, Jasper, Loukides, Stelios, van Maaren, Maurits, Panzner, Petr, Pite, Helena, Spanevello, Antonio, Stenberg, Henning, Striz, Ilja, Thio, Boony, Vasakova, Martina Koziar, Conti, Diego, Fokkens, Wytske, Lau, Susanne, Scadding, Glenis K., Van Staeyen, Elizabeth, Hellings, Peter W., and Bjermer, Leif

Published
2023

40. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023

Author

Fokkens, W. J., Viskens, An Sofie, Backer, Vibeke, Conti, Diego, de Corso, Eugenio, Gevaert, Philippe, Scadding, Glenis K., Wagemann, Martin, Sprekelsen, Manuel Bernal, Chaker, Adam, Heffler, Enrico, Han, Joseph K., Staeyen, Elizabeth Van, Hopkins, Claire, Mullol, Joaquim, Peters, Anju, Reitsma, Sietze, Senior, Brent A., Hellings, Peter W., Fokkens, W. J., Viskens, An Sofie, Backer, Vibeke, Conti, Diego, de Corso, Eugenio, Gevaert, Philippe, Scadding, Glenis K., Wagemann, Martin, Sprekelsen, Manuel Bernal, Chaker, Adam, Heffler, Enrico, Han, Joseph K., Staeyen, Elizabeth Van, Hopkins, Claire, Mullol, Joaquim, Peters, Anju, Reitsma, Sietze, Senior, Brent A., and Hellings, Peter W.

Abstract

Severe chronic rhinosinusitis with nasal polyps (CRSwNP) is a debilitating disease with a significant impact on the quality of life (QoL). It is typically characterized by a type 2 inflammatory reaction and by comorbidities such as asthma, allergies and NSAID-Exacerbated Respiratory Disease (N-ERD). Here, the European Forum for Research and Education in Allergy and Airway diseases discusses practical guidelines for patients on biologic treatment. Criteria for the selection of patients who would benefit from biologics were updated. Guidelines are proposed concerning the monitoring of the drug effects that provide recognition of res-ponders to the therapy and, subsequently, the decision about continuation, switching or discontinuation of a biologic. Further-more, gaps in the current knowledge and unmet needs were discussed.

Published
2023

48. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19

Author

Rouadi, Philip W., primary, Idriss, Samar A., additional, Bousquet, Jean, additional, Laidlaw, Tanya M., additional, Azar, Cecilio R., additional, Al-Ahmad, Mona S., additional, Yañez, Anahi, additional, Al-Nesf, Maryam Ali Y., additional, Nsouli, Talal M., additional, Bahna, Sami L., additional, Abou-Jaoude, Eliane, additional, Zaitoun, Fares H., additional, Hadi, Usamah M., additional, Hellings, Peter W., additional, Scadding, Glenis K., additional, Smith, Peter K., additional, Morais-Almeida, Mario, additional, Maximiliano Gómez, René, additional, Gonzalez Diaz, Sandra N., additional, Klimek, Ludger, additional, Juvelekian, Georges S., additional, Riachy, Moussa A., additional, Canonica, Giorgio Walter, additional, Peden, David, additional, Wong, Gary W.K., additional, Sublett, James, additional, Bernstein, Jonathan A., additional, Wang, Lianglu, additional, Tanno, Luciana K., additional, Chikhladze, Manana, additional, Levin, Michael, additional, Chang, Yoon-Seok, additional, Martin, Bryan L., additional, Caraballo, Luis, additional, Custovic, Adnan, additional, Ortego-Martell, Jose Antonio, additional, Lesslar, Olivia J.Ly, additional, Jensen-Jarolim, Erika, additional, Ebisawa, Motohiro, additional, Fiocchi, Alessandro, additional, and Ansotegui, Ignacio J., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results